Compounds > azacitidine

azacitidine and Neoplasms, Bone Marrow

azacitidine has been researched along with Neoplasms, Bone Marrow in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basak, G; Boguradzki, P; Chmarzyńska-Mróz, E; Drozd-Sokołowska, J; Dwilewicz-Trojaczek, J; Jędrzejczak, W; Karakulska-Prystupiuk, E; Kulikowska, A; Paluszewska, M; Stefaniak, A; Waszczuk-Gajda, A1
Chim, CS; Drexler, HG; Fung, TK; Wan, TS; Wong, KF; Wong, KY1
Gore, SD1
Cornfield, DB1
Beck, MN; Bourloud, KB; Gross, N; Mühlethaler, A; Yan, P1

Reviews

1 review(s) available for azacitidine and Neoplasms, Bone Marrow

ArticleYear
New ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndrome.
    Hematology. American Society of Hematology. Education Program, 2011, Volume: 2011

    Topics: Azacitidine; Bone Marrow Neoplasms; DNA Modification Methylases; Enzyme Inhibitors; Humans; Maintenance Chemotherapy; Myelodysplastic Syndromes

2011

Other Studies

4 other study(ies) available for azacitidine and Neoplasms, Bone Marrow

ArticleYear
Azacitidine for Relapse After Allogeneic Stem Cell Transplantation-Single-Center Study.
    Transplantation proceedings, 2018, Volume: 50, Issue:7

    Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Bone Marrow Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasm Recurrence, Local; Neoplasm, Residual; Primary Myelofibrosis; Retrospective Studies; Transplantation, Homologous; Young Adult

2018
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
    Journal of translational medicine, 2011, Nov-14, Volume: 9

    Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Base Sequence; Bone Marrow Neoplasms; Case-Control Studies; Cell Line, Tumor; Demography; DNA Methylation; Female; Humans; Male; MicroRNAs; Middle Aged; Molecular Sequence Data; Myeloproliferative Disorders; Philadelphia Chromosome

2011
Erythroblastic sarcoma, an extremely rare variant of myeloid sarcoma.
    Human pathology, 2012, Volume: 43, Issue:11

    Topics: Abnormal Karyotype; Adenocarcinoma; Aged; Azacitidine; Biopsy, Large-Core Needle; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Erythroblasts; Erythropoietin; Fatal Outcome; Humans; Lymph Nodes; Male; Myelodysplastic Syndromes; Rare Diseases; Rectal Neoplasms; Sarcoma, Myeloid

2012
Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma.
    Genes, chromosomes & cancer, 2003, Volume: 36, Issue:2

    Topics: Azacitidine; Bone Marrow Neoplasms; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Exons; Gene Amplification; Gene Expression Regulation; Gene Silencing; Humans; Hyaluronan Receptors; Immunohistochemistry; N-Myc Proto-Oncogene Protein; Neoplasm Staging; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Promoter Regions, Genetic; Tumor Cells, Cultured

2003